PTAB challenges

As a senior PTAB practitioner analyzing US patent 9,667,337, here is a summary of the AIA trial proceedings and their strategic implications for a defendant.

Proceedings overview

There has been one IPR filed against US patent 9,667,337, which the PTAB denied instituting on discretionary grounds; this means the patent survived the challenge on a procedural issue without a decision on the merits, leaving the claims untested by the PTAB.

IPR2026-00033 — Samsung Electronics Co., Ltd. et al. v. Massively Broadband LLC

• Type: Inter Partes Review
• Filed: 2025-10-22
• Status: Discretionary Denial. The Board declined to institute an IPR trial for reasons unrelated to the substantive invalidity arguments.
• Judge panel: Public records for this proceeding do not yet list the assigned panel, but discretionary denials are often handled by senior PTAB judges or through a process involving the Director.
• Petition grounds: While the specific petition is not yet publicly available through all portals, an IPR of this nature typically challenges key claims of the patent based on prior art under 35 U.S.C. § 102 (anticipation) or § 103 (obviousness).
• Institution decision: The proceeding was denied institution on 2026-04-09. A "Discretionary Denial" indicates the Board used its authority under 35 U.S.C. § 314(a) to refuse the petition. This type of denial is often based on the Fintiv factors, which consider the status of a parallel district court case involving the same patent, weighing factors like the trial date's proximity and the overlap of issues. This avoids potentially duplicative efforts and inconsistent outcomes between the PTAB and district courts.
• Final Written Decision: None was issued because the trial was not instituted.
• Settlement / termination: The proceeding was not terminated due to settlement.
• Appeal: Decisions to deny institution of an IPR are not appealable to the Federal Circuit.
• Defensive value: For a defendant, this outcome is a mixed signal. The patent owner successfully avoided PTAB review, which can be seen as a win. However, because the denial was discretionary and not based on the merits of the invalidity arguments, the patent has not been "hardened" or validated. The prior art and arguments raised by Samsung may still be potent, and they can be used in district court litigation or a future PTAB proceeding under different circumstances.

Strategic summary

The landscape for US patent 9,667,337 is defined by the single, un-instituted IPR. All claims of the patent remain UNTESTED by the PTAB. No claims have been CANCELED or SUSTAINED. This procedural victory for the patent owner means the core validity of the claims has not been adjudicated in a post-grant review, leaving them vulnerable to the same or similar challenges in the future.

Critically, the discretionary denial means no statutory estoppel applies under 35 U.S.C. § 315(e)(2). Samsung, its co-petitioners, and their privies are not barred from re-petitioning the PTAB or raising the same invalidity grounds in district court. A new defendant faces no estoppel whatsoever from this proceeding and is free to file its own IPR, though it may face a similar discretionary denial if it is also in co-pending litigation with a near-term trial date.

The pattern signals a common strategy for patent owners: using active, fast-moving district court litigation to shield a patent from the risks of PTAB review via the Fintiv framework. The petitioner, Samsung, is a major technology company, indicating this patent is likely being asserted in high-stakes litigation.

Recommended next steps

For a defendant currently facing an assertion of US patent 9,667,337:

• The patent remains vulnerable: The discretionary denial should not be mistaken for a substantive victory for the patent owner. The invalidity arguments presented by Samsung were never tested by the PTAB. A defendant should obtain Samsung's IPR petition and analyze its arguments, as they may provide a strong foundation for an invalidity defense in district court.
• No FWD to review: There is no Final Written Decision that analyzes the patentability of any claim. The core task is to assess the merits of potential prior art challenges from a fresh perspective.
• Consider your litigation posture: If you are sued in a district with a long time-to-trial, a new IPR may be a viable strategy, as the Fintiv factors would be less likely to warrant a discretionary denial. The legal landscape around discretionary denials has been dynamic, so the viability of a new petition should be assessed based on the latest USPTO guidance.